Yaneisys Martin Rojas
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 228 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,943, more than ten times the $104 reported in 2021. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 228 payments — averaging $22.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$921
- UCB, Inc.$752
- Neurocrine Biosciences, Inc.$722
- AstraZeneca$350
- Eisai Inc.$261
- Lilly USA, LLC$215
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,051100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $921 |
| UCB, Inc. | 19 | $752 |
| Neurocrine Biosciences, Inc. | 41 | $722 |
| AstraZeneca(2 entities) | 16 | $350 |
| Eisai Inc. | 12 | $261 |
| Lilly USA, LLC | 10 | $215 |
| Otsuka America Pharmaceutical, Inc. | 9 | $182 |
| Axsome Therapeutics, Inc. | 7 | $177 |
| Avion Pharmaceuticals | 8 | $158 |
| SK Life Science, Inc. | 6 | $144 |
| Merz Pharmaceuticals, LLC | 8 | $138 |
| Pfizer | 6 | $123 |
| Johnson & Johnson | 4 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $97 |
| Novartis | 4 | $94 |
| Boston Scientific | 2 | $77 |
| Teva Pharmaceuticals USA, Inc. | 3 | $69 |
| Acadia Pharmaceuticals Inc | 3 | $52 |
| Harmony Biosciences LLC | 1 | $50 |
| Aprecia Pharmaceuticals, LLC | 2 | $44 |
| Springworks Therapeutics, Inc. | 2 | $42 |
| Lundbeck LLC | 2 | $40 |
| Catalyst Pharmaceuticals, Inc. | 1 | $35 |
| Amneal Pharmaceuticals LLC | 2 | $35 |
| CSL Behring | 1 | $26 |
| MDD US Operations, LLC | 1 | $24 |
| Insightec,inc | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Neurelis, Inc. | 1 | $23 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| Biogen | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$125
How this compares
$5,051 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Other family in Miami
- Patrick SzarazMiami$327K
- Yamila MelendezMiami$212K
- Suzan RosenMiami$129K
- Felipe NovoaMiami$110K
- Pamela DudkiewiczMiami$89K
- Stacy FeemsterMiami$51K
- Estrella Moreno RodriguezMiami$30K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.